1. Home
  2. AP vs MOLN Comparison

AP vs MOLN Comparison

Compare AP & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ampco-Pittsburgh Corporation

AP

Ampco-Pittsburgh Corporation

HOLD

Current Price

$8.99

Market Cap

138.0M

Sector

Industrials

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.90

Market Cap

158.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AP
MOLN
Founded
1929
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Fluid Controls
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
138.0M
158.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AP
MOLN
Price
$8.99
$4.90
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.38
AVG Volume (30 Days)
328.8K
2.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$285.71
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$3.36
52 Week High
$9.55
$5.11

Technical Indicators

Market Signals
Indicator
AP
MOLN
Relative Strength Index (RSI) 67.40 67.30
Support Level $2.39 $3.50
Resistance Level N/A N/A
Average True Range (ATR) 0.78 0.17
MACD 0.08 0.04
Stochastic Oscillator 80.94 75.73

Price Performance

Historical Comparison
AP
MOLN

About AP Ampco-Pittsburgh Corporation

Ampco-Pittsburgh Corp is manufacturing and selling engineered, specialty metal products and customized equipment. It operates in two business segments namely the Forged and Cast Engineered Products segment and the Air and Liquid Processing segment. The Forged and Cast Engineered Products segment produces forged hardened steel rolls, cast rolls, and open-die forged products. Forged hardened steel rolls are used in cold rolling mills by producers of steel, aluminum, and other metals whereas, the Air and Liquid Processing segment includes Aerofin, Buffalo Air Handling, and Buffalo Pumps. The company generates a majority of its revenue from the Forged and Cast Engineered Products segment. It has a business presence in the United States and other countries.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: